Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives-Reference-Cited by-同舟云学术

Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives

Published:2020-06-15 Issue:4 Volume:34 Page:247-256
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Krendyukov Andriy^ORCID,Nasy Dévi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40290-020-00341-0.pdf

Reference34 articles.

1. Khedkar P, Sturgis M. Want better access to physicians? Understand what’s top of mind. How to broaden your reach—and target your messaging—to engage healthcare providers. ZS Associates; 2016. https://www.zs.com/-/media/pdfs/ph_mar_wp_afm_acm_2016_es_v4.pdf. Accessed 8 June 2020.

2. Colter T, Guan M, Mahdavian M, Razzaq S, Scheider J. What the future science of B2B sales growth looks like. New York: McKinsey & Company; 2018.

3. Frey D, Fernando R, Wright C. Drivers of change to pharmaceutical commercial models. ZS Associates and Eyeforpharma report. https://www.zs.com/-/media/files/publications/public/whitepapers/zs-e4p-pharma-model-change-drivers.pdf?la=en. Accessed 15 Jan 2020.

4. A mapping of Sunshine and transparency laws, regulations and codes in Europe. https://mhe-sme.org/wp-content/uploads/2017/09/Mapping-of-Sunshine-Laws-in-Europe.pdf. Accessed 10 May 2020.

5. Krendyukov A. Innovative oncology products: time to revisit the strategy development? ESMO Open. 2019;4(5):e000571.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of right communication with healthcare providers and patients about the new levothyroxine formulation: an expert opinion from Asia Pacific Thyroid Advisory Board;Current Medical Research and Opinion;2024-08-07

2. A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014–2018);Contemporary Clinical Trials;2022-09

3. Data-enriched edible pharmaceuticals (DEEPs): Patients' preferences, perceptions, and acceptability of new dosage forms and their digital aspects – An interview study;Exploratory Research in Clinical and Social Pharmacy;2022-06

4. Medical Affairs and Innovative Medicinal Product Strategy Development;Pharmaceutical Medicine;2022-03-13

5. Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond;Pharmaceutical Medicine;2021-12-31